MSC-omics: The Next Frontier for MSC Characterization and Standardization
Mesenchymal stem/stromal cells (MSCs) are multipotent progenitor cells that possess robust anti-inflammatory and immunomodulatory properties. Due to their apparent safety and their ability to secrete a diverse repertoire of bioactive molecules1, MSCs are rapidly gaining favor as a viable therapeutic option for a number of diseases2, including SARS-CoV-2. Although initially identified in bone marrow, MSCs can be […]
Developing a Robust CGT Manufacturing Process
In this presentation, OrganaBio’s Head of Process & Product Development highlights our approach to setting the stage early in process development for sustained manufacturing success. This talk was originally given at the 2020 Cell & Gene Therapy Bioprocessing & Commercialization global conference. The conference brought together 856 members of the cell and gene therapy community […]
Simple Science: Cardiac RegenMed
Simple Science: Cardiac Regenerative Medicine The field of cardiac regenerative medicine is rapidly developing solutions to treat the millions of people around the world affected by cardiac illnesses. The articles summarized in the Simple Science posts below outline a few of the recent advancements in cardiac tissue engineering, disease modeling, and the role of the […]